Related Experiment Videos
High specificity PCR screening for 22q11.2 microdeletion in three different ethnic groups
A C Pereira1, R F R Corrêa, G F Mota
1Laboratório de Genética e Cardiologia Molecular, Instituto do Coração, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brasil.
Summary
A PCR assay effectively screens for 22q11.2 deletions, a common cause of congenital heart defects. This cost-effective method shows high specificity across diverse ethnic groups, making it valuable for at-risk patient populations.
Area of Science:
- Genetics
- Molecular Biology
- Cardiology
Background:
- Congenital heart defects (CHDs) are the most frequent human birth defects.
- A 22q11.2 deletion is linked to DiGeorge syndrome and sporadic congenital cardiovascular disease.
Purpose of the Study:
- To evaluate a PCR assay for screening 22q11.2 deletions in an ethnically diverse urban population.
- To determine the assay's specificity and effectiveness in identifying chromosomal abnormalities associated with CHDs.
Main Methods:
- Utilized PCR with specific markers (D22S941, D22S944, D22S264) to screen for 22q11.2 deletion.
- Assessed assay specificity in 149 unrelated individuals from three ethnic groups (white, mulatto, black).
- Compared heterozygosity indices across different ethnicities.
Main Results:
- The PCR assay demonstrated an overall population specificity of 98.3%.
- No significant differences in heterozygosity indices or assay specificity were found among the ethnic groups.
- P-values for ethnicity comparisons were 0.43 (D22S944), 0.22 (D22S264), and 0.58 (D22S941).
Conclusions:
- The PCR assay is a specific and reliable method for screening 22q11.2 deletions.
- This cost-effective assay is suitable for large-scale screening of patients at risk for CHDs.
- PCR offers advantages in speed, automation, and cost compared to fluorescence in situ hybridization.